Skip to main content
. 2022 Apr 8;162(4):920–929. doi: 10.1016/j.chest.2022.03.045

Table 2.

Access to Care and Treatment Characteristics Among White and Black Veterans With Clinical Stage I NSCLC Undergoing Resection in the VHA

Access to Care and Treatment Characteristics White (n = 8,356) Black (n = 1,486) P Value
Wait time to surgery, median (IQR), d 64 (63) 70 (74) .090
PET scan 6,872 (82.2) 1,234 (83.0) .455
EBUS 899 (10.8) 184 (12.4) .065
Mediastinoscopy 640 (7.7) 108 (7.3) .600
EBUS or mediastinoscopy 1,599 (19.1) 296 (19.9) .480
Oncology appointment 2,174 (26.0) 420 (28.3) .069
Tumor size, mean ± SD, mm 23.30 ± 10.6 23.5 ± 10.9 .460
Resection .189
 Lobectomy 5,795 (69.4) 1,069 (71.9)
 Wedge 1,846 (22.1) 299 (20.1)
 Segment 523 (6.3) 93 (6.3)
 Pneumonectomy 135 (1.6) 18 (1.2)
 Unknown 57 (0.7) 7 (0.5)
Surgical approach .480
 VATS 3,188 (38.2) 564 (38.0)
 Thoracotomy 4,614 (55.2) 851 (57.3)
 Unknown 544 (6.5) 71 (4.8)
Grade .208
 I 1,008 (12.1) 186 (12.5)
 II 4,084 (48.9) 688 (46.3)
 III 2,516 (30.1) 484 (32.6)
 IV 113 (1.4) 22 (1.5)
 Unknown 635 (7.6) 106 (7.1)
Histology < .001
 Adenocarcinoma 4,309 (51.6) 895 (60.2)
 Squamous cell carcinoma 2,940 (35.2) 396 (26.6)
 Other 1,106 (13.2) 193 (13.0)
 Unknown 1 (0.0) 2 (0.1)
Lymph node sampling
 Median (IQR) 6 (2,12) 6 (2,11) .002
 ≥ 10 2,599 (33.3) 425 (30.6) .050
Pathological STAGE .468
 I 7,004 (83.8) 1,260 (84.8)
 II 640 (7.7) 113 (7.6)
 III 310 (3.7) 61 (4.1)
 IV 33 (0.4) 10 (0.7)
 Unknown 369 (4.4) 42 (2.8)

Data are expressed as No. (%) unless otherwise indicated. EBUS = endobronchial ultrasound; IQR = interquartile range; NSCLC = non-small cell lung cancer; VATS = video-assisted thoracic surgery; VHA = Veterans Health Administration.